The Esophageal Dilator Set ecosystem spans upstream component sourcing, midstream device assembly, and downstream clinical delivery. Upstream, raw‑material suppliers provide medical‑grade polymers, stainless steel, and silicone that meet ISO 13485 standards. Midstream actors include OEM manufacturers that fabricate and sterilize the dilators, technology firms that embed sizing or imaging software, and system integrators that bundle accessories into ready‑to‑use kits. Downstream, distributors channel finished sets to hospital purchasing groups, while service providers ensure training and maintenance. End users—gastroenterology and surgical units—apply the kits in therapeutic dilation, completing the value chain by generating procedural revenue and clinical outcomes. Value is captured through device sales, service contracts, and data licensing for procedure outcomes, while manufacturers leverage scale economies to reduce per‑unit cost.